US Patent 7718762 Cancer vaccines containing epitopes of oncofetal antigen
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+327 characters)
Article
Patent abstract
Disclosed are fragments of oncofetal antigen, otherwise known as immature laminin receptor protein that specifically stimulate one T cell subclass. The fragments may be formulated into compositions for potentiating T cell-mediated responses in mammalian cancer patients. They also have therapeutic uses in vitro.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Adel L. Barsoum0
James W. Rohrer0
Joseph H. Coggin, Jr.0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07718762 Cancer vaccines containing epitopes of oncofetal antigen US Patent 7718762 Cancer vaccines containing epitopes of oncofetal antigen
Infobox
Patent Number
077187620
Patent Number
77187620
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
077187620
Date of Patent
May 18, 2010
0Patent Application Number
105232770
Date Filed
August 4, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07718762 Cancer vaccines containing epitopes of oncofetal antigen
Infobox
Is a
Patent jurisdiction
Patent number
07718762
Date of patent
May 18, 2010
Patent application number
10523277
Date Filed
August 4, 2003
Patent primary examiner
Find more entities like US Patent 7718762 Cancer vaccines containing epitopes of oncofetal antigen
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
